Finance

Lists
8049:HKG
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd
2,48 HK$
0,00%
(0,00) 1D
16 հոկ, 10:41:52 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 8049...
Mkt. cap
1,39 մլրդ
Avg. vol.
11,60 հզր
Volume
0,00
P/E ratio
5,42
52-wk high
3,00 HK$
52-wk low
1,82 HK$
EPS
0,46 HK$
Shares outstanding
172,50 մլն
No. of employees
1 հզր
Mkt. cap
1,39 մլրդ
Avg. vol.
11,60 հզր
Volume
0,00
P/E ratio
5,42
52-wk high
3,00 HK$
52-wk low
1,82 HK$
EPS
0,46 HK$
Shares outstanding
172,50 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
About Jilin Provnc Hnn Chnglng Bio-pharm CoLtd
CEO-
Employees1,11 հզր
Founded1989
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
231,50 մլն
231,50 մլն
217,52 մլն
217,52 մլն
Cost of goods sold
33,49 մլն
33,49 մլն
34,91 մլն
34,91 մլն
Cost of revenue
33,49 մլն
33,49 մլն
34,91 մլն
34,91 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
156,87 մլն
156,87 մլն
120,15 մլն
120,15 մլն
Operating expense
152,20 մլն
152,20 մլն
106,73 մլն
106,73 մլն
Total operating expenses
185,69 մլն
185,69 մլն
141,64 մլն
141,64 մլն
Operating income
45,81 մլն
45,81 մլն
75,89 մլն
75,89 մլն
Other non operating income
-
-
-
-
EBT including unusual items
70,80 մլն
70,80 մլն
75,04 մլն
75,04 մլն
EBT excluding unusual items
69,92 մլն
69,92 մլն
75,04 մլն
75,04 մլն
Income tax expense
22,86 մլն
22,86 մլն
13,62 մլն
13,62 մլն
Effective tax rate
32,29%
32,29%
18,15%
18,15%
Other operating expenses
-4,67 մլն
-4,67 մլն
-13,42 մլն
-13,42 մլն
Net income
47,94 մլն
47,94 մլն
61,42 մլն
61,42 մլն
Net profit margin
20,71%
20,71%
28,24%
28,24%
Earnings per share
-
-
-
-
Interest and investment income
24,34 մլն
24,34 մլն
-
-
Interest expense
-223,00 հզր
-223,00 հզր
-849,00 հզր
-849,00 հզր
Net interest expenses
24,12 մլն
24,12 մլն
-849,00 հզր
-849,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
52,31 մլն
52,61 մլն
82,69 մլն
82,69 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps